Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

Authors: Mohammad Bosaeed, Hanan H Balkhy, Sultan Almaziad, Haya A Aljami, Hind Alhatmi, Hala Alanazi, Mashael Alahmadi, Ayah Jawhary, Mohammed W Alenazi, Abdulrahman Almasoud, Rawan Alanazi, Mustapha Bittaye, Jeremy Aboagye, Nahla Albaalharith, Sarah Batawi, Pedro Folegatti, Fernando Ramos Lopez, Katie Ewer, Khalid Almoaikel, Majed Aljeraisy, Adel Alothman, Sarah C Gilbert, Naif Khalaf Alharbi

Published: 2021-11-03

DOI: 10.1016/s2666-5247(21)00193-2

Source: Full article

---

Abstract

No abstract found.